Background

Alprolix is a global leader in the haemophilia rare disease space, a treatment trusted to give patients of every age meaningful protection from the devastating joint bleeds that define the condition. From first diagnosis to lifelong management, Alprolix stands between patients and the damage that robs them of movement, independence, and quality of life.

Solution

A promotional campaign spanning four life-stage concepts, designed to show HCPs across the EMENAR region exactly what Alprolix protection means at every chapter of a patient's journey.

The campaign will speak directly to Haematologists, Haemophilia specialists, Haemo-oncologists, and Primary Care Physicians, the clinicians who make the decisions that shape their patients' lives.

Each concept captures a distinct and defining moment: the newly diagnosed child, the adolescent pushing at the boundaries of what their body can do, the young adult building a life on their own terms, and the older patient protecting the decades they've already fought to keep.

All four concepts will be rooted in the creative territory established by the 2018 US campaign, carrying its emotional core into the cultural and clinical landscape of EMENAR, where patient stories, healthcare systems, and specialist relationships each carry their own weight.

This is not a campaign about a treatment. It's a campaign about what a life looks like when protection is real.